Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Invested Capital (2017 - 2025)

Fortress Biotech has reported Return on Invested Capital over the past 7 years, most recently at 0.12% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.12% for Q4 2025, down 1551.0% from a year ago — trailing twelve months through Dec 2025 was 0.12% (down 1551.0% YoY), and the annual figure for FY2025 was 0.29%, down 388287.0%.
  • Return on Invested Capital for Q4 2025 was 0.12% at Fortress Biotech, up from 1.75% in the prior quarter.
  • Over the last five years, Return on Invested Capital for FBIO hit a ceiling of 102.37% in Q1 2024 and a floor of 111.17% in Q2 2023.
  • Median Return on Invested Capital over the past 5 years was 0.57% (2021), compared with a mean of 2.47%.
  • Biggest five-year swings in Return on Invested Capital: tumbled -10994bps in 2023 and later skyrocketed 12175bps in 2024.
  • Fortress Biotech's Return on Invested Capital stood at 0.85% in 2021, then tumbled by -219bps to 2.69% in 2022, then surged by 1008bps to 24.47% in 2023, then plummeted by -37bps to 15.39% in 2024, then crashed by -101bps to 0.12% in 2025.
  • The last three reported values for Return on Invested Capital were 0.12% (Q4 2025), 1.75% (Q3 2025), and 15.39% (Q4 2024) per Business Quant data.